Ionis presents positive results from Phase 3 NEURO-TTRansform study at International Symposium on Amyloidosis ...Middle East

PR Newswire - News
Ionis presents positive results from Phase 3 NEURO-TTRansform study at International Symposium on Amyloidosis
Ionis and AstraZeneca's eplontersen demonstrated a statistically significant and clinically meaningful change from baseline for co-primary and secondary endpoints at 35 weeks compared to the external placebo group Eplontersen achieved an 81.2% reduction in the co-primary endpoint of serum...

Hence then, the article about ionis presents positive results from phase 3 neuro ttransform study at international symposium on amyloidosis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ionis presents positive results from Phase 3 NEURO-TTRansform study at International Symposium on Amyloidosis )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News